EP3212233
BLÖNDUÐ MEÐFERÐ SEM SJÚKDÓMSLÆKNING
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.10.2015EP published:
24.6.2020EP application number:
15856100.1
EP translation filed:
10.7.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
29.10.2035Expiry date:
29.10.2025Next due date:
31.10.2025
Title:
COMBINATION THERAPY FOR TREATMENT OF DISEASE
Timeline
Today
30.10.2015EP application
24.6.2020EP Publication
10.7.2020Translation submitted
15.8.2020Registration published
29.10.2025Expires
Owner
Name:
Mereo BioPharma 5, Inc.Address:
800 Chesapeake Drive, Redwood City, CA 94063-4748, US
Inventor
Name:
MURRIEL, Christopher LamondAddress:
Redwood City, CA 94063, US
Name:
HOEY, Timothy CharlesAddress:
Hillsborough California 94010, US
Name:
GURNEY, Austin L.Address:
San Francisco California 94114, US
Name:
RODA, Julie MichelleAddress:
Foster City California 94404, US
Name:
SRIVASTAVA, Minu K.Address:
Sunnyvale California 94087, US
Name:
PARK, InkyungAddress:
Palo Alto California 94303, US
Name:
DUPONT, JakobAddress:
Hillsborough California 94010, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201462073634 PDate:
31.10.2014Country:
US
Number:
201562127172 PDate:
2.3.2015Country:
US
Number:
201562192133 PDate:
14.7.2015Country:
US
Number:
201562242567 PDate:
16.10.2015Country:
US
Classification
Categories:
A61K 39/395, A61P 35/00, C07K 16/18, A61K 31/282, A61K 31/519, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 9.9.2020
Expires: 29.10.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 7.9.2021
Expires: 29.10.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.9.2022
Expires: 29.10.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.10.2023
Expires: 29.10.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.10.2024
Expires: 29.10.2025
Payer: Árnason Faktor ehf.